We previously demonstrated that PPARγ overexpression induces an oncogenic addiction in these tumors by showing that the loss of PPARγ expression inhibited bladder cancer cell viability7, most notably observed in cell lines presenting PPARG gain or amplification6,8. This evidence concerns the gene PPARG and urinary bladder cancer.